ReviewHeliyon2024

Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods.

Yuxi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.